Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election
Company Chairman and President, Serguei Melnik will take over as interim CEO over the course of the campaign and election period.
ORLANDO, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) has announced that Company CEO, Gareth Sheridan will be stepping aside from his role for three months to enter the Irish Presidential election. The Nomination Hearings followed by the Election will take place over the course of September and October.
During this period, Co-Founder and Chairman, Serguei Melnik will take over the responsibilities of CEO and guide the company through the final 2025 framework towards the target NDA filing in 2026. Mr. Melnik, a corporate strategy expert will continue to execute the Company's strategic development and focus on shareholder value. Mr. Melnik has over 20 years experience in Capital markets.
'I have made the decision to temporarily step aside as CEO following the support and encouragement I have received asking me to put my name forward for the election for President of Ireland. Rest assured, Nutriband is in very safe hands. While most often we talk about AVERSA as our big opportunity, it is our tight knit team that is really our core asset. I look forward to watching Nutriband continue to hit its planned targets between now and December,' said Mr. Sheridan.
The FDA recently granted Nutriband's meeting request for AVERSA Fentanyl
AVERSA FENTANYL has the potential to be the world's first abuse-deterrent opioid patch designed to deter the abuse and misuse and reduce the risk of accidental exposure of transdermal fentanyl patches. AVERSA FENTANYL has the potential to reach peak annual US sales of $80 million to $200 million.1 While initially concentrating on the US market, the unmet medical need for adequate pain management is a global problem, and our goal is to make AVERSA FENTANYL available in all major medical markets in the world.
The AVERSA™ abuse deterrent technology is protected by a broad international intellectual property portfolio with patents issued in 46 countries including the United States, Europe, Japan, Korea, Russia, China, Canada, Mexico, and Australia.
____________________________________________________
1 Health Advances Aversa Fentanyl market analysis report 2022
About AVERSA™ Abuse-Deterrent Transdermal Technology
Nutriband's AVERSA™ abuse-deterrent transdermal technology incorporates aversive agents into transdermal patches to prevent the abuse, diversion, misuse, and accidental exposure of drugs with abuse potential. The AVERSA™ abuse-deterrent technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, such as fentanyl, while making sure that these drugs remain accessible to those patients who really need them. The technology is covered by a broad intellectual property portfolio with patents granted in the United States, Europe, Japan, Korea, Russia, China, Canada, Mexico, and Australia.
About Nutriband Inc.
We are primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Our lead product under development is an abuse-deterrent fentanyl patch incorporating our AVERSA™ abuse-deterrent technology. AVERSA™ technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.
The Company's website is www.nutriband.com. Any material contained in or derived from the Company's websites or any other website is not part of this press release.
Forward-Looking Statements
Certain statements contained in this press release, including, without limitation, statements containing the words ''believes,' 'anticipates,' 'expects' and words of similar import, constitute 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve both known and unknown risks and uncertainties. The Company's actual results may differ materially from those anticipated in its forward-looking statements as a result of a number of factors, including those including the Company's ability to develop its proposed abuse-deterrent fentanyl transdermal system and other proposed products, its ability to obtain patent protection for its abuse technology, its ability to obtain the necessary financing to develop products and conduct the necessary clinical testing, its ability to obtain Federal Food and Drug Administration approval to market any product it may develop in the United States and to obtain any other regulatory approval necessary to market any product in other countries, including countries in Europe, its ability to market any product it may develop, its ability to create, sustain, manage or forecast its growth; its ability to attract and retain key personnel; changes in the Company's business strategy or development plans; competition; business disruptions; adverse publicity and international, national and local general economic and market conditions and risks generally associated with an undercapitalized developing company, as well as the risks contained under 'Risk Factors' and 'Management's Discussion and Analysis of Financial Condition and Results of Operations' in the Company's Form S-1, Forms 10-K's and Forms 10-Q's, and the Company's other filings with the Securities and Exchange Commission. Except as required by applicable law, we undertake no obligation to revise or update any forward-looking statements to reflect any event or circumstance that may arise after the date hereof.
Contact Information:
Nutriband Inc.
Phone: 407-377-6695
Email: [email protected]
SOURCE: Nutriband Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
23 minutes ago
- CBS News
Florida Keys fishermen seek tariffs as costs rise and prices fall
Local fishermen in the Florida Keys say they are looking for a lifeline as costs go up and the value of their catch goes down. They hope tariffs on foreign fish imports can help level the playing field. Replacing hydraulic hoses is a recurring cost for fisherman Jorge Blanco's boat. He got a discount on parts today but said if he had paid the full price, it would take more than one fishing trip to make that money back. "The amount of lobster I would have to catch—that's ten thousand pounds of lobster," Blanco said. Blanco was featured in a recent YouTube video in which he hoped to sound the alarm on his industry. He said expenses have gone up, but the value of the lobsters he catches has gone down. Blanco said foreign fish imported into the U.S. have lowered the market value of local catches. He said buyers prefer fish from overseas because it is sold for less than his asking price. "It's crippled us. They're asking for a quarter of what we're asking for," Blanco said. According to the U.S. Department of Agriculture, U.S. seafood imports have increased almost every year from 1995 through 2023. The National Oceanic and Atmospheric Administration says the U.S. now imports nearly 80% of its seafood. Last year, the top seafood importers into the U.S. were Canada, Chile, India, Indonesia and Vietnam. The Trump administration has imposed 35% tariffs on Canada and 50% tariffs on India. "I think a tariff could bring up the price on that product, will discourage these restaurants and these buyers to buy overseas and buy a local product here," Blanco said. Jerome Young, executive director of the Florida Keys Commercial Fisherman's Association, said food lovers in the Keys would appreciate knowing their seafood was caught locally. "Domestically people would pay more if they just knew," Young said. "They've gotta know what they're eating." Blanco said other variables he has to worry about every day on the water include never being able to guarantee he will catch enough fish to make the trip worth it. On top of that, there are limits on how many fish he can bring to shore. Blanco said if the market does not change in the next year, he may have to shut his business down.
Yahoo
an hour ago
- Yahoo
Homeowners struggle with soaring insurance costs amid concerning nationwide trends: 'Uninsurable future'
Homeowners struggle with soaring insurance costs amid concerning nationwide trends: 'Uninsurable future' Across the U.S., soaring insurance premiums are putting pressure on homeowners, and for some, making it impossible to keep their homes. As extreme weather becomes more severe, these costs are expected to rise even further. What's happening? According to MarketWatch, home insurance premiums jumped 20% between 2022 and 2024, with another 8% increase expected in 2025. Natural disasters like wildfires and floods are driving the surge, prompting insurers to pull out of high-risk states such as California and Florida. One California homeowner on the state's FAIR Plan saw his annual premium jump from $7,000 to $12,000 in a year, without ever filing a claim. "I mean, it's just crazy," the homeowner said about the sudden price increase, per MarketWatch. Housing counselors in Florida say more first-time buyers are falling behind on mortgage payments as insurance becomes unaffordable. This issue is especially tough on FHA borrowers, who tend to have lower incomes and minimal savings. With insurance required by lenders, many are forced to choose between paying premiums and buying groceries. Similar trends are unfolding nationwide. In places like Colorado, homeowners are scrambling as insurers drop coverage, while working-class families are being left unprotected by shrinking access to affordable plans. Why is this concerning? These rising costs reflect a broader pattern: human-caused pollution is overheating the planet, leading to stronger storms and longer wildfire seasons. That drives insurers away from high-risk areas, leaving families without coverage or paying drastically higher rates. How concerned are you about your energy bills increasing this summer? Very Somewhat Not much Not at all Click your choice to see results and speak your mind. Officials warn this could lead to an "uninsurable future," and the burden falls heaviest on working-class communities and people of color, especially in states with the steepest premium hikes. What's being done about it? States like California and Florida have expanded public insurance options. Some cities are investing in wildfire buffers and flood defenses. But the root solution is reducing pollution that is heating the planet. You can help by electrifying your home, driving less, and supporting climate-friendly policies. Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet. Solve the daily Crossword
Yahoo
an hour ago
- Yahoo
C3.ai Stock Plummets 25% After ‘Completely Unacceptable' Preliminary Results
Key Takeaways Shares of lost a quarter of their value after the AI software provider posted preliminary sales figures that were significantly weaker than expected. CEO Tom Siebel called the sales results 'completely unacceptable' and blamed a reorganization of leadership and his health as contributing factors. With Monday's losses, the former AI darling's stock has lost more than half its value this of (AI) plunged after the AI software provider posted preliminary financial results that fell well short of the company's own expectations and that the CEO called "unacceptable." The former AI darling's stock fell over 25% Monday to just above $16. It has lost more than half its value since the year began. said it expects to report an adjusted loss of $57.7 million to $57.9 million, on revenue of $70.2 million to $70.4 million for its fiscal first quarter, down from $87.2 million in revenue the same period a year earlier. In May, the company had guided for revenue of $100 to $109 million. The company is set to release its full results on Sept. 3. CEO Calls The Numbers 'Completely Unacceptable' CEO Tom Siebel called the sales figures 'completely unacceptable,' and pointed to disruptions from a reorganization of the company's leadership and his health as contributing factors to the company's poor performance. The company announced in late July that it is actively searching for a successor to Siebel, who said he was diagnosed with an autoimmune disease and has experienced 'multiple hospitalizations and vision impairment.' D.A. Davidson analysts called the results 'catastrophic' in a note to clients Sunday, and downgraded stock to 'underperform' following the results, writing they view "business trends as likely to get worse before they get better." Analysts at Wedbush maintained an "outperform" rating for stock after the results, but lowered their target to $23 from a Street high of $35 on Monday, calling the sales miss "brutal." "It will take lots of time to regain Street confidence and build further momentum in the stock given the weakness in its operational performance," the Wedbush analysts wrote. Read the original article on Investopedia
